Cleavage of four carbon-carbon bonds during biosynthesis of the griseorhodin a spiroketal pharmacophore.

The rubromycins, such as gamma-rubromycin, heliquinomycin, and griseorhodin A, are a family of extensively modified aromatic polyketides that inhibit HIV reverse transcriptase and human telomerase. Telomerase inhibition crucially depends on the presence of a spiroketal moiety that is unique among aromatic polyketides. Biosynthetic incorporation of this pharmacophore into the rubromycins results in a dramatic distortion of the overall polyketide structure, but how this process is achieved by the cell has been obscure. To identify the enzymes involved in spiroketal construction, we generated 14 gene-deletion variants of the griseorhodin A biosynthetic gene cluster isolated from the tunicate-associated bacterium Streptomyces sp. JP95. Heterologous expression and metabolic analysis allowed for an assignment of most genes to various stages of griseorhodin tailoring and pharmacophore generation. The isolation of the novel advanced intermediate lenticulone, which exhibits cytotoxic, antibacterial, and elastase-inhibiting activity, provided direct evidence that the spiroketal is formed by cleavage of four carbon-carbon bonds in a pentangular polyketide precursor. This remarkable transformation is followed by an epoxidation catalyzed by an unusual cytochrome P450/NADPH:ubiquinone oxidoreductase pair that utilizes a saturated substrate. In addition, the absolute configuration of griseorhodin A was determined by quantum-chemical circular dichroism (CD) calculations in combination with experimental CD measurements.

[1]  A. Burger,et al.  Cancer stem cell targeted agents: therapeutic approaches and consequences. , 2008, Current opinion in molecular therapeutics.

[2]  G. Bringmann,et al.  The online assignment of the absolute configuration of natural products: HPLC-CD in combination with quantum chemical CD calculations. , 2008, Chirality.

[3]  B. Shen,et al.  Identification of fredericamycin E from Streptomyces griseus: Insights into fredericamycin A biosynthesis highlighting carbaspirocycle formation. , 2008, Journal of natural products.

[4]  W. Gerwick,et al.  GNAT-Like Strategy for Polyketide Chain Initiation , 2007, Science.

[5]  H. Reissig,et al.  Rubromycins: Structurally Intriguing, Biologically Valuable, Synthetically Challenging Antitumour Antibiotics , 2007 .

[6]  J. Piel,et al.  Biosynthesis of pentangular polyphenols: deductions from the benastatin and griseorhodin pathways. , 2007, Journal of the American Chemical Society.

[7]  J. Ahn,et al.  Cloning, sequencing, and characterization of the pradimicin biosynthetic gene cluster of Actinomadura hibisca P157-2. , 2007, Journal of microbiology and biotechnology.

[8]  Andriy Luzhetskyy,et al.  Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. , 2007, Natural product reports.

[9]  Marko D. Mihovilovic,et al.  Enzyme Mediated Baeyer-Villiger Oxidations , 2006 .

[10]  J. Rohr,et al.  Characterization of kinetics and products of the Baeyer-Villiger oxygenase MtmOIV, the key enzyme of the biosynthetic pathway toward the natural product anticancer drug mithramycin from Streptomyces argillaceus. , 2005, Journal of the American Chemical Society.

[11]  J. Blanchard,et al.  Structure and functions of the GNAT superfamily of acetyltransferases. , 2005, Archives of biochemistry and biophysics.

[12]  C. Hertweck,et al.  Formation of the aureothin tetrahydrofuran ring by a bifunctional cytochrome p450 monooxygenase. , 2004, Journal of the American Chemical Society.

[13]  B. Moore,et al.  EncM, a versatile enterocin biosynthetic enzyme involved in Favorskii oxidative rearrangement, aldol condensation, and heterocycle-forming reactions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Šturdı́k,et al.  Structural aspects of flavonoids as trypsin inhibitors. , 2004, European journal of medicinal chemistry.

[15]  M. Platzer,et al.  Unprecedented Diversity of Catalytic Domains in the First Four Modules of the Putative Pederin Polyketide Synthase , 2004, Chembiochem : a European journal of chemical biology.

[16]  J. Rohr,et al.  Biosynthesis of the antitumor chromomycin A3 in Streptomyces griseus: analysis of the gene cluster and rational design of novel chromomycin analogs. , 2004, Chemistry & biology.

[17]  D. Bearss,et al.  Telomere inhibition and telomere disruption as processes for drug targeting. , 2003, Annual review of pharmacology and toxicology.

[18]  J. P. Pardo,et al.  Diversity, taxonomy and evolution of medium-chain dehydrogenase/reductase superfamily. , 2003, European journal of biochemistry.

[19]  M. Ozawa,et al.  Cloning, sequencing and heterologous expression of the medermycin biosynthetic gene cluster of Streptomyces sp. AM-7161: towards comparative analysis of the benzoisochromanequinone gene clusters. , 2003, Microbiology.

[20]  F. Guengerich.  Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. , 2003, Archives of biochemistry and biophysics.

[21]  U. Rix,et al.  Modification of post-PKS tailoring steps through combinatorial biosynthesis. , 2002, Natural product reports.

[22]  J. Piel,et al.  A gene cluster from a marine Streptomyces encoding the biosynthesis of the aromatic spiroketal polyketide griseorhodin A. , 2002, Chemistry & biology.

[23]  Dick B Janssen,et al.  Identification of a Baeyer–Villiger monooxygenase sequence motif , 2002, FEBS letters.

[24]  J. Bailey,et al.  Collinone, a new recombinant angular polyketide antibiotic made by an engineered Streptomyces strain. , 2001, The Journal of antibiotics.

[25]  G. Bringmann,et al.  Determination of the Absolute Configurations of γ‐Rubromycin and Related Spiro Compounds by Quantum Chemical CD Calculations , 2000 .

[26]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Shah,et al.  Cloning, characterization and heterologous expression of a polyketide synthase and P-450 oxidase involved in the biosynthesis of the antibiotic oleandomycin. , 2000, The Journal of antibiotics.

[28]  K. Sakaguchi,et al.  Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety. , 2000, Biochemistry.

[29]  K. Murphy,et al.  PCR-mediated gene replacement in Escherichia coli. , 2000, Gene.

[30]  A. Hizi,et al.  Structural and Biosynthetic Investigations of the Rubromycins , 2000 .

[31]  D. Hopwood,et al.  Chemical characterisation of disruptants of the Streptomyces coelicolor A3(2) actVI genes involved in actinorhodin biosynthesis. , 2000, The Journal of antibiotics.

[32]  C. Wharton,et al.  Novel natural product 5,5-trans-lactone inhibitors of human alpha-thrombin: mechanism of action and structural studies. , 1998, Biochemistry.

[33]  A. Ortiz,et al.  Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series. , 1997, Journal of medicinal chemistry.

[34]  M. Eppink,et al.  Purification and properties of 4-hydroxybenzoate 1-hydroxylase (decarboxylating), a novel flavin adenine dinucleotide-dependent monooxygenase from Candida parapsilosis CBS604 , 1997, Journal of bacteriology.

[35]  K. Nishikawa,et al.  Heliquinomycin, a new inhibitor of DNA helicase, produced by Streptomyces sp. MJ929-SF2 II. Structure determination of heliquinomycin. , 1997, The Journal of antibiotics.

[36]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[37]  A. Pühler,et al.  Gene disruption and gene replacement in Streptomyces via single stranded DNA transformation of integration vectors. , 1991, Nucleic acids research.

[38]  W. Schleif,et al.  Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer site. , 1990, Molecular pharmacology.

[39]  K. Suetsuna,et al.  Isolation of structure of dideoxy-griseorhodin C produced by a Streptomyces sp. , 1989 .

[40]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[41]  Mark S. Gordon,et al.  Self‐consistent molecular orbital methods. XXIII. A polarization‐type basis set for second‐row elements , 1982 .

[42]  K. Chater,et al.  Streptomyces albus G mutants defective in the SalGI restriction-modification system. , 1980, Journal of general microbiology.

[43]  B. Schönecker,et al.  Antibiotika aus actinomyceten. zur stereochemie der griseorhodine , 1979 .

[44]  P. C. Hariharan,et al.  The influence of polarization functions on molecular orbital hydrogenation energies , 1973 .